These findings indicate that <i>MEG3</i> contributes to an aggressive tumor phenotype, highlighting the need for further examination into its mechanistic role in hepatoblastoma and its potential as a biomarker or therapeutic target. The gene discussed is MEG3; the disease is hepatoblastoma.